<document xmlns="http://cnx.rice.edu/cnxml">
  <title>Diuretics</title>
  <metadata xmlns:md="http://cnx.rice.edu/mdml">
    <md:title>Diuretics</md:title>
    <md:content-id>m00298</md:content-id>
    <md:uuid>7c063d34-fc4e-4f81-926c-a400aa89ff66</md:uuid>
  </metadata>
<content>
<section class="learning-objectives" id="sect-00001">
<title>Learning Outcomes</title>
<para id="para-00001">By the end of this section, you should be able to:</para>
<list id="list-00001"> 
<item>Identify the characteristics of the diuretic drugs used to treat heart failure.</item>
<item>Explain the indications, actions, adverse reactions, and interactions of the diuretic drugs used to treat heart failure.</item>
<item>Describe nursing implications of diuretic drugs used to treat heart failure.</item>
<item>Explain the client education plan related to diuretic drugs used to treat heart failure.</item></list>
</section>
<para id="para-00002"><term id="term-00001">Diuretics</term> were introduced in (<link document="m00313">Antihypertensive and Antianginal Drugs</link>). This chapter discusses diuretics that are used in heart failure, specifically loop diuretics and thiazide and thiazide-like diuretics. Typically, potassium-sparing diuretics, except for mineralocorticoid receptor agonists, are used sparingly in the treatment of heart failure because the combination of ACE inhibitor or ARB with a potassium-sparing diuretic can lead to increased potassium levels.</para>
<section id="sect-00002">
<section id="sect-00003">
<title>Loop Diuretics</title>
<para id="para-00003"><term class="no-emphasis" id="term-00002">Loop diuretics</term> block the reabsorption of sodium and chloride in the loop of Henle, which is located in the renal tubule. Due to the way the sodium pump works, loop diuretics also block the reabsorption of potassium. Loop diuretics in general are more potent than thiazide diuretics since the majority of sodium and chloride reabsorption occurs in the loop of Henle. Loop diuretics are often the first choice of diuretics in treating heart failure.</para>
<note class="clinical-tip" id="note-00001">
<title>Potassium Supplements</title>
<para id="para-00004">Clients should be informed they may have to take prescribed potassium supplements when taking loop diuretics.</para>
</note>
<note class="safety-alert" id="note-00002">
<title>Diuretics</title>
<para id="para-00005">Loop diuretics are potent diuretics that can lead to profound dehydration and electrolyte loss.</para>
</note>
</section>
<section id="sect-00004">
<title>Thiazide and Thiazide-Like Diuretics</title>
<para id="para-00006">As discussed in <link document="m00313">Antihypertensive and Antianginal Drugs</link>, <term class="no-emphasis" id="term-00003">thiazide and thiazide-like diuretics</term> block the reabsorption of sodium and chloride in the distal renal tubule. Due to the nature of sodium reabsorption, thiazide and thiazide-like diuretics cause potassium loss as well as sodium loss.</para>
<para id="para-00007"><link target-id="table-00001" document="m00298"/> lists common loop diuretics and thiazide/thiazide-like diuretics used in heart failure and typical routes and dosing for adult clients.</para>
<table class="vertically-tight" id="table-00001">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="2*"/>
<thead>
<row>
<entry valign="middle" align="center"><span class="blue-text">Drug</span></entry>
<entry valign="middle" align="center"><span class="blue-text">Routes and Dosage Ranges</span></entry>
</row>
</thead>
<tbody>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00004">Bumetanide</term><newline/>
(<term class="no-emphasis" id="term-00005">Bumex</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Heart failure:</emphasis><newline/>
<emphasis effect="italics">Oral:</emphasis> 0.5–1 mg twice daily; maximum dose: 10 mg daily.<newline/>
<emphasis effect="italics">Intramuscular/intravenous (IV):</emphasis> 0.5–10 mg once or twice daily; maximum dose: 10 mg daily.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00006">Furosemide</term><newline/>
(<term class="no-emphasis" id="term-00007">Lasix</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Edema:</emphasis> 20–80 mg orally twice daily; maximum dose: 600 mg daily. (Doses exceeding 80 mg daily must be monitored carefully with frequent follow-up and laboratory monitoring.)</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00008">Torsemide</term><newline/>
(<term class="no-emphasis" id="term-00009">Demadex</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Heart failure</emphasis>: 10–20 mg orally daily, titrated; maximum dose: 200 mg daily.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00010">Chlorothiazide</term><newline/>
(<term class="no-emphasis" id="term-00011">Diuril</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Edema:</emphasis> 250–500 mg IV once or twice daily; maximum dose: 1000 mg daily.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00012">Chlorthalidone</term><newline/>
(<term class="no-emphasis" id="term-00013">Thalitone</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Edema:</emphasis> 50–100 mg orally every other day; maximum dose: 100 mg every other day.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00014">Hydrochlorothiazide</term><newline/>
(<term class="no-emphasis" id="term-00015">Microzide</term>, <term class="no-emphasis" id="term-00016">HCTZ</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Edema:</emphasis> 25–100 mg orally daily.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00017">Indapamide</term><newline/>
(<term class="no-emphasis" id="term-00018">Lozol</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Edema: </emphasis>2.5 mg orally daily; maximum dose: 5 mg daily.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00019">Metolazone</term><newline/>
(<term class="no-emphasis" id="term-00020">Zaroxolyn</term>)</entry>
<entry valign="middle" align="left"><emphasis effect="italics">Edema or heart failure:</emphasis> 5–20 mg orally once daily.</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Emphasis Table: Diuretics Used in Heart Failure</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
</section>
<section id="sect-00005">
<title>Adverse Effects and Contraindications</title>
<para id="para-00008">Adverse effects include severe anaphylactic/anaphylactoid reaction, excessive loss of water and electrolytes, ototoxicity, tinnitus and hearing loss, vertigo, dizziness, aplastic anemia, thrombocytopenia, agranulocytosis, hemolytic anemia, leukopenia, anemia, Stevens-Johnson syndrome, drug rash, and cramping/diarrhea.</para>
<para id="para-00009">Clients with hypersensitivity to diuretics should not take this classification of drugs. All diuretics should be used with caution in older clients and/or clients with hepatic or renal impairment, arrhythmias, or gout.</para>
<para id="para-00010"><link target-id="table-00002" document="m00474"/> is a drug prototype table for diuretics featuring furosemide (a loop diuretic). It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications. (Hydrochlorothiazide, a thiazide/thiazide-like diuretic, was featured in <link document="m00313">Antihypertensive and Antianginal Drugs</link>.)</para>
<table class="vertically-tight" id="table-00002">
<tgroup cols="2">
<colspec colnum="1" colname="col1" colwidth="1*"/>
<colspec colnum="2" colname="col2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top">
<emphasis effect="bold"><span class="blue-text">Drug Class</span></emphasis><newline/>
Loop diuretic<newline count="2"/>
<emphasis effect="bold"><span class="blue-text">Mechanism of Action</span></emphasis><newline/>
Blocks the reabsorption of sodium in the loop of Henle, which causes sodium and water to be excreted</entry>
<entry valign="top">
<emphasis effect="bold"><span class="blue-text">Drug Dosage</span></emphasis><newline/>
<emphasis effect="italics">Edema:</emphasis> 20–80 mg orally twice daily; maximum dose: 600 mg daily. (Doses exceeding 80 mg daily must be monitored carefully with frequent follow-up and laboratory monitoring.)</entry>
</row>
<row>
<entry valign="top"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
Hypertension<newline/>
Congestion and/or edema in heart failure<newline count="2"/>
<emphasis effect="bold"><span class="blue-text">Therapeutic Effects</span></emphasis><newline/>
Lowers blood pressure<newline/>
Decreases edema</entry>

<entry valign="top">
<emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
Aminoglycoside (may increase risk of ototoxicity)<newline count="2"/>

<emphasis effect="bold"><span class="blue-text">Food Interactions</span></emphasis><newline/>
No significant interactions</entry>
</row>
<row>
<entry valign="top">
<emphasis effect="bold"><span class="blue-text">Adverse Effects</span></emphasis><newline/>
Severe anaphylactic/anaphylactoid reaction<newline/>
Orthostatic hypotension<newline/>
Excessive loss of water and electrolytes<newline/>
Ototoxicity<newline/>
Tinnitus and hearing loss<newline/>
Vertigo<newline/>
Dizziness<newline/>
Aplastic anemia<newline/>
Thrombocytopenia<newline/>
Agranulocytosis<newline/>
Hemolytic anemia<newline/>
Leukopenia<newline/>
Anemia<newline/>
Stevens-Johnson syndrome<newline/>
Drug rash<newline/>
Cramping/diarrhea</entry>

<entry valign="top">
<emphasis effect="bold"><span class="blue-text">Contraindications</span></emphasis><newline/>
Allergy to furosemide<newline/>
Anuria<newline count="2"/>

Caution:<newline/>
Hepatic disease<newline/>
Renal disease</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Prototype Table: Furosemide</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
</section>
<section id="sect-00006">
<title>Nursing Implications</title>
<para id="para-00011">The nurse should do the following for clients who are taking diuretics:</para>
<list id="list-00002">
<item>Assess the client’s blood pressure and pulse on an ongoing basis with initial dosing and intermittently during drug therapy.</item>
<item>Assess the client for electrolyte imbalances and hyperglycemia, as well as the client’s urine output. Urine output should be at least 30 mL/hour or 600 mL/24 hours.</item>
<item>Assess and monitor for adverse effects, drug and food interactions, and contraindications.</item>
<item>Provide client teaching regarding the drug and when to call the health care provider. See the following for client teaching guidelines.</item>
</list>
<note class="client-teaching" id="note-00003">
<para id="para-00012"><emphasis effect="bold">The client taking any type of diuretic should:</emphasis></para>
<list list-type="bulleted" id="list-00003">
<item>Take diuretic as prescribed by the health care provider.</item>
<item>Take diuretic earlier in the day (morning) so that diuresis occurs before sleeping times.</item>
<item>Report a weight loss or weight gain greater than 2 pounds a day or 5 pounds a week to the health care provider.</item>
<item>Notify their health care provider about symptoms such as dizziness, lightheadedness, or fainting because these could be related to low blood pressure.</item>
</list>
<para id="para-00013"><emphasis effect="bold">The client taking a loop diuretic should:</emphasis></para>
<list list-type="bulleted" id="list-00004">
<item>Report adverse effects such as dizziness or lightheadedness, fatigue, increased bleeding, tinnitus, weakness, and leg cramps to the provider.</item>
<item>Eat potassium-rich foods to replace potassium.</item>
</list>
</note>
<note class="black-box" id="note-00004">
<para id="para-00014"><emphasis effect="bold">Diuretics</emphasis></para>
<para id="para-00015">Loop diuretics are a potent diuretic and could lead to diuresis with water and electrolyte depletion.</para>
</note>
<note class="unfolding-casestudy" id="note-00005">
<para id="para-00016">Read the following clinical scenario to answer the questions that follow.</para>
<para id="para-00017">Anna Rodriguez is an 85-year-old Mexican American client who presents to her health care provider with an exacerbation of heart failure. Anna reports increasing shortness of breath with self-care activities. She also shares that she is no longer going to the senior center because getting in and out of the car leaves her short of breath and fatigued. She also reports that her feet feel “heavy” and that she has gained 3 pounds in the last 1 to 2 weeks. Anna sleeps on two pillows and does not awaken during the night with shortness of breath. She has also had a persistent itchy, dry cough and asks if she has a respiratory infection. The cough is nonproductive, and Anna reports no fever, chills, achy feeling, congestion, or chest pain.</para>
<para id="para-00018">Anna reports following a low-sodium diet and does not engage in exercise. She is a nonsmoker and does not drink alcohol.</para>
<para id="para-00019"><emphasis effect="bold">History</emphasis><newline/>
Heart failure with preserved ejection fraction 
Hypothyroidism</para>
<para id="para-00020"><emphasis effect="bold">Current Medications</emphasis><newline/>
Lisinopril 10 mg twice daily<newline/>
Levothyroxine 50 mcg once daily</para>
<table class="vertically-tight" id="table-00003">
<tgroup cols="3">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<colspec colnum="3" colname="c3" colwidth="1*"/>
<thead>
<row>
<entry valign="top" align="center" namest="c1" nameend="c2"><span class="blue-text">Vital Signs</span></entry>
<entry valign="top" align="center"><span class="blue-text">Physical Examination</span></entry>
</row>
</thead>
<tbody>
<row>
<entry valign="top"><emphasis effect="italics">Temperature:</emphasis></entry>
<entry valign="top">98.2°F</entry>
<entry valign="top" morerows="6">
<list list-type="bulleted" id="list-00005">
<item><emphasis effect="italics">Head, eyes, ears, nose, throat (HEENT):</emphasis> Within normal limits</item>
<item><emphasis effect="italics">Neurological:</emphasis> Within normal limits</item>
<item><emphasis effect="italics">Cardiovascular:</emphasis> No jugular venous distension, 1+ pitting edema of feet and ankles. S1 and S2 heard on heart auscultation. No S3 noted. Brisk capillary refill in nailbeds of hands and feet.</item>
<item><emphasis effect="italics">Respiratory:</emphasis> Crackles auscultated in lung bases bilaterally</item>
<item><emphasis effect="italics">Gastrointestinal:</emphasis> Abdominal sounds heard in all four quadrants, no tenderness, no distension</item>
<item><emphasis effect="italics">Integumentary:</emphasis> Skin appropriate for age.</item></list></entry>
</row>
<row>
<entry valign="top"><emphasis effect="italics">Heart rate:</emphasis></entry>
<entry valign="top">95 beats/min</entry>
</row>
<row>
<entry valign="top"><emphasis effect="italics">Respiratory rate:</emphasis></entry>
<entry valign="top">22 breaths/min</entry>
</row>
<row>
<entry valign="top"><emphasis effect="italics">Blood pressure:</emphasis></entry>
<entry valign="top">158/94 mm Hg</entry>
</row>
<row>
<entry valign="top"><emphasis effect="italics">Height:</emphasis></entry>
<entry valign="top">5’4”</entry>
</row>
<row>
<entry valign="top"><emphasis effect="italics">Weight:</emphasis></entry>
<entry valign="top">152 pounds (up 7 pounds per client)</entry>
</row>
</tbody>
</tgroup>
</table>
<exercise id="exer-00001"><problem id="prob-00001"><para id="para-00021"><link class="os-embed" url="#exercise/PHAR_Ch19_Sec2_UCSQ1"/></para></problem></exercise>
<exercise id="exer-00002"><problem id="prob-00002"><para id="para-00022"><link class="os-embed" url="#exercise/PHAR_Ch19_Sec5_UCSQ2"/></para></problem></exercise>
</note>
</section>
</section>
</content>
<glossary>
<definition id="def-00001"><term>diuretic</term> <meaning>a classification of drugs that induce sodium loss and increase urine flow; typically used to treat hypertension, heart failure, and volume overload states </meaning></definition>
</glossary>
</document>